ES8605818A1 - Un metodo para la preparacion del compuesto antibiotico, estearato de acetil-eritromicina - Google Patents

Un metodo para la preparacion del compuesto antibiotico, estearato de acetil-eritromicina

Info

Publication number
ES8605818A1
ES8605818A1 ES539349A ES539349A ES8605818A1 ES 8605818 A1 ES8605818 A1 ES 8605818A1 ES 539349 A ES539349 A ES 539349A ES 539349 A ES539349 A ES 539349A ES 8605818 A1 ES8605818 A1 ES 8605818A1
Authority
ES
Spain
Prior art keywords
compound according
acetyl
erythromycin
compositions containing
stearate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES539349A
Other languages
English (en)
Spanish (es)
Other versions
ES539349A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Yhtyma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtyma Oy filed Critical Orion Yhtyma Oy
Publication of ES8605818A1 publication Critical patent/ES8605818A1/es
Publication of ES539349A0 publication Critical patent/ES539349A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring (AREA)
ES539349A 1984-01-06 1985-01-04 Un metodo para la preparacion del compuesto antibiotico, estearato de acetil-eritromicina Expired ES8605818A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen

Publications (2)

Publication Number Publication Date
ES8605818A1 true ES8605818A1 (es) 1986-04-01
ES539349A0 ES539349A0 (es) 1986-04-01

Family

ID=8089251

Family Applications (1)

Application Number Title Priority Date Filing Date
ES539349A Expired ES8605818A1 (es) 1984-01-06 1985-01-04 Un metodo para la preparacion del compuesto antibiotico, estearato de acetil-eritromicina

Country Status (38)

Country Link
US (1) US4599326A (enExample)
JP (1) JPS60158197A (enExample)
KR (1) KR900006237B1 (enExample)
AT (1) AT386414B (enExample)
AU (1) AU565688B2 (enExample)
BE (1) BE901411A (enExample)
BG (1) BG43189A3 (enExample)
CA (1) CA1224461A (enExample)
CH (1) CH666275A5 (enExample)
CS (1) CS247191B2 (enExample)
CY (1) CY1462A (enExample)
DE (1) DE3500179A1 (enExample)
DK (1) DK149776C (enExample)
ES (1) ES8605818A1 (enExample)
FI (1) FI77249C (enExample)
FR (1) FR2557878B1 (enExample)
GB (1) GB2152502B (enExample)
HK (1) HK11590A (enExample)
HU (1) HU196221B (enExample)
IE (1) IE57967B1 (enExample)
IL (1) IL73885A (enExample)
IS (1) IS2968A7 (enExample)
IT (1) IT1184304B (enExample)
KE (1) KE3841A (enExample)
LU (1) LU85721A1 (enExample)
MA (1) MA20316A1 (enExample)
MX (1) MX156277A (enExample)
NL (1) NL8403979A (enExample)
NO (1) NO160263C (enExample)
NZ (1) NZ210606A (enExample)
PH (1) PH22471A (enExample)
PL (1) PL144349B1 (enExample)
PT (1) PT79777B (enExample)
RO (1) RO91262B (enExample)
SE (1) SE461854B (enExample)
SU (1) SU1410866A3 (enExample)
YU (1) YU44485B (enExample)
ZA (1) ZA8410143B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US7399488B2 (en) * 2002-07-05 2008-07-15 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opiods and other drugs
CA2543945A1 (en) * 2003-10-31 2005-05-12 Alza Corporation Compositions and dosage forms for enhanced absorption of 3-amino-n-butyl-phosphinic acid
EP3326617A1 (en) 2004-06-12 2018-05-30 Collegium Pharmaceutical, Inc. Abuse-deterrent drug formulations
EP2457580A1 (en) 2004-08-25 2012-05-30 The UAB Research Foundation Absorption enhancers for drug administration
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
CA2714867A1 (en) 2006-06-23 2007-12-27 Candace B. Pert Non-aggregated pharmaceutically active peptide
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
KR102512178B1 (ko) 2011-05-18 2023-03-20 메더리스 다이어비티즈, 엘엘씨 개선된 펩티드 제약
AU2013347975B2 (en) 2012-11-20 2018-07-26 Mederis Diabetes, Llc Improved peptide pharmaceuticals for insulin resistance
CA2891929C (en) 2012-11-20 2022-07-19 Eumederis Pharmaceuticals, Inc. Improved peptide pharmaceuticals
WO2014140699A1 (en) * 2013-03-13 2014-09-18 Calyx Chemicals And Pharmaceuticals Ltd A novel process of liberation of erythromycin and preparation of its salts
EP4397374A3 (en) 2014-05-28 2024-10-16 Mederis Diabetes, LLC Improved peptide pharmaceuticals for insulin resistance
WO2017222575A1 (en) 2016-06-23 2017-12-28 Collegium Pharmaceutical, Inc. Process of making more stable abuse-deterrent oral formulations
RU2019142102A (ru) 2017-05-19 2021-06-21 Лунелла Байотек, Инк. Антимитосцины: направленные ингибиторы митохондриального биогенеза для эрадикации злокачественных стволовых клеток
US11497759B2 (en) 2017-12-01 2022-11-15 Lunella Biotech, Inc. Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
EP4483958A3 (en) 2018-02-06 2025-03-05 Aegis Therapeutics, LLC Intranasal epinephrine formulations and methods for the treatment of disease
JP6941224B2 (ja) 2018-02-06 2021-09-29 イージス セラピューティクス,エルエルシー 疾患の処置のための鼻腔内エピネフリン製剤及び方法
KR20210104830A (ko) * 2018-12-17 2021-08-25 루넬라 바이오테크 인코포레이티드 항노화를 위한 삼중 조합 요법
BR112021011963A2 (pt) * 2018-12-17 2021-09-08 Lunella Biotech, Inc. Terapias de combinação tripla para alvejamento de mitocôndria e exterminação de células-tronco de câncer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011117B (de) * 1953-11-16 1957-06-27 Abbott Lab Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen
FR1179208A (fr) * 1953-11-16 1959-05-21 Abbott Lab Procédé de préparation de sels d'érythromycine
GB834397A (en) * 1958-07-29 1960-05-04 Lilly Co Eli Therapeutic compositions comprising erythromycin esters
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
PT79777B (en) 1986-10-21
DK5884D0 (da) 1984-01-06
MA20316A1 (fr) 1985-10-01
PT79777A (en) 1985-01-01
JPH029040B2 (enExample) 1990-02-28
IE850022L (en) 1985-07-06
JPS60158197A (ja) 1985-08-19
HU196221B (en) 1988-10-28
SE8406671D0 (sv) 1984-12-28
IS2968A7 (is) 1985-04-03
HUT37628A (en) 1986-01-23
PL251457A1 (en) 1985-11-05
FI850023A0 (fi) 1985-01-03
FI77249C (fi) 1989-02-10
SE461854B (sv) 1990-04-02
PL144349B1 (en) 1988-05-31
FI850023L (fi) 1985-07-07
CY1462A (en) 1989-07-21
IE57967B1 (en) 1993-06-02
DE3500179A1 (de) 1985-07-18
RO91262A (ro) 1987-06-30
IT1184304B (it) 1987-10-28
GB8432368D0 (en) 1985-02-06
DK149776C (da) 1987-04-21
PH22471A (en) 1988-09-12
CH666275A5 (de) 1988-07-15
ZA8410143B (en) 1985-08-28
NZ210606A (en) 1987-08-31
DK149776B (da) 1986-09-29
YU44485B (en) 1990-08-31
KE3841A (en) 1989-04-07
CA1224461A (en) 1987-07-21
AU565688B2 (en) 1987-09-24
KR900006237B1 (ko) 1990-08-27
DK5884A (da) 1985-07-07
LU85721A1 (fr) 1985-07-24
IT8519012A0 (it) 1985-01-04
NO850007L (no) 1985-07-08
ES539349A0 (es) 1986-04-01
FI77249B (fi) 1988-10-31
NL8403979A (nl) 1985-08-01
CS247191B2 (en) 1986-12-18
BG43189A3 (en) 1988-04-15
ATA985A (de) 1988-01-15
YU2085A (en) 1987-12-31
SE8406671L (sv) 1985-07-07
AT386414B (de) 1988-08-25
GB2152502B (en) 1987-10-07
HK11590A (en) 1990-02-23
RO91262B (ro) 1987-07-01
IL73885A0 (en) 1985-03-31
FR2557878A1 (fr) 1985-07-12
US4599326A (en) 1986-07-08
GB2152502A (en) 1985-08-07
AU3705984A (en) 1985-07-11
MX156277A (es) 1988-08-04
KR850005452A (ko) 1985-08-26
IL73885A (en) 1988-10-31
NO160263B (no) 1988-12-19
DE3500179C2 (enExample) 1989-08-24
NO160263C (no) 1989-03-29
SU1410866A3 (ru) 1988-07-15
FR2557878B1 (fr) 1988-01-15
BE901411A (fr) 1985-04-16

Similar Documents

Publication Publication Date Title
ES8605818A1 (es) Un metodo para la preparacion del compuesto antibiotico, estearato de acetil-eritromicina
ES8900093A1 (es) Un procedimiento para preparar nuevos antibioticos macrociclicos que contienen anillos de dihidrobenzofurano y de pirano
IL91159A0 (en) Tetrahydro-1-benz-(c,d)-indole-propionic acid sulphonamides,their preparation and pharmaceutical compositions containing them
EP0215654A3 (en) Macrolide antibiotics and their preparation
DE2962643D1 (en) 3,5-dihydroxypentanoic ester derivatives having antihyperlipaemic activity, their manufacture and pharmaceutical compositions containing them
KR850004246A (ko) 헤테로-폴리사이클 방향족 화합물의 제법
JPS56161393A (en) Beta-lactam compound
EP0544907A1 (en) Antibacterial penem esters derivatives
GB1360972A (en) Cephalosporin compounds
GB1488420A (en) Aminoglycosides
US5142042A (en) Process for preparing well crystallized alkali metal salts of 3, 7-substituted 7-aminocephalosporanic acid derivatives
GB1525626A (en) Tetrazolethiomethyl cephalosporin compounds
SE7509107L (sv) Aryloxi- eller aryltioinnehallande sekoprostaglandiner
ES8404326A1 (es) Un procedimiento para preparar el nuevo compuesto ester guayacilico del acido 1-metil-5-p-toluilpirrol-2-acetico.
ES8307236A1 (es) Un procedimiento para la preparacion de ranitidina.
HK91289A (en) Bicyclocatechol derivatives
SE8303727D0 (sv) Cefalosporinantibiotika
GB2009158A (en) Thienylmalonic Acid and Diesters Thereof
IE44698L (en) Cephalosporins.
EP0381915B1 (en) Process for preparing alkali metal salts of 3,7-substituted 7-aminocephalosporanic acid derivatives.
IE42705L (en) Cephalosporin compounds.
JPS5653682A (en) Production of novel rifamycin derivative
JPS5427546A (en) Liquid crystal compound
GB2012260A (en) 4-desacetoxy-4 alpha -hydroxyindole- dihydroindoles, pharmaceutical formulations containing them and their use as antimitotic agents
KR880002879A (ko) (5r,6s,8r)-6-(1-하이드록시에틸)-2-(3r-피롤리딘-2-온-3-일) 티오페넴-3-카복실산

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401